Literature DB >> 6135525

Triazolam concentration-effect relationships in healthy subjects.

G Baktir, H U Fisch, P Huguenin, J Bircher.   

Abstract

Triazolam was used to study the plasma concentration-effect relationship of a benzodiazepine because it has a very short plasma t1/2. A standard hypnotic dose of 0.25 mg was given by mouth to six healthy subjects, and blood samples were drawn when the subjects had to perform a battery of psychologic tests. Only the digit-symbol substitution test, the card-sorting test according to numbers, and the visual analog scale (energetic-lethargic) gave significant results. Analysis of the concentration-effect relationship in individuals indicated a wide scatter of the data. Mean values revealed a trend for a learning effect in the card-sorting test. The results are consistent with the hypothesis that triazolam is well suited for a study of concentration-effect relationships, but better psychologic tests would be desirable.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6135525     DOI: 10.1038/clpt.1983.152

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  10 in total

Review 1.  The use of kinetic-dynamic interactions in the evaluation of drugs.

Authors:  D B Campbell
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

2.  Understanding the hysteresis loop conundrum in pharmacokinetic/pharmacodynamic relationships.

Authors:  Christopher Louizos; Jaime A Yáñez; M Laird Forrest; Neal M Davies
Journal:  J Pharm Pharm Sci       Date:  2014       Impact factor: 2.327

3.  Excessive motor impairment two hours after triazolam in the elderly.

Authors:  H U Fisch; G Baktir; G Karlaganis; C Minder; J Bircher
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

4.  Simultaneous modeling of the pharmacokinetic and pharmacodynamic properties of benzodiazepines. II. Triazolam.

Authors:  S K Gupta; E H Ellinwood; A M Nikaido; D G Heatherly
Journal:  Pharm Res       Date:  1990-06       Impact factor: 4.200

5.  Dose equivalence of midazolam and triazolam. A psychometric study based on flicker sensitivity, reaction time and digit symbol substitution test.

Authors:  H J Sostmann; H Sostmann; C Crevoisier; J Bircher
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

Review 6.  Pharmacokinetic-pharmacodynamic relationships for benzodiazepines.

Authors:  B E Laurijssens; D J Greenblatt
Journal:  Clin Pharmacokinet       Date:  1996-01       Impact factor: 6.447

7.  Comparison of the effects of quazepam and triazolam on cognitive-neuromotor performance.

Authors:  A M Nikaido; E H Ellinwood
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

8.  Troleandomycin-triazolam interaction in healthy volunteers: pharmacokinetic and psychometric evaluation.

Authors:  D Warot; L Bergougnan; D Lamiable; I Berlin; G Bensimon; P Danjou; A J Puech
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

9.  Specific effects of the benzodiazepine midazolam on visual receptive fields in light and dark adapted human subjects.

Authors:  M Groner; H U Fisch; F Walder; R Groner; D Hofer; U Koelbing; I Duss; R Bianchi; B Bircher
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

10.  Study of the potential reversal of triazolam memory and cognitive deficits by RU 41 656 in healthy subjects.

Authors:  A Patat; M J Klein; A Surjus; M Hucher; J Granier
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.